Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020
Masoud Dara(World Health Organization Regional Office for Europe), Martin J. Boeree(Radboud University Nijmegen), Tanja Schmidt(World Health Organization Regional Office for Europe), Ihor Perehinets(World Health Organization Regional Office for Europe), Giorgi Kuchukhidze(World Health Organization Regional Office for Europe), W. Leif Van Grinsven(World Health Organization Regional Office for Europe), Askar Yedilbayev(World Health Organization Regional Office for Europe)
Cited by 38
Related Papers
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
|European Respiratory Journal|2019|176
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
|European Respiratory Journal|2019|130